TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway
Cell Biology International · 2023
DOI: 10.1002/cbin.12006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2023. Verfasst von Xiaohong Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Podocytes. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Excellent talent fund project, development fund of Affiliated Hospital of Xuzhou Medical University, Suqian guiding science and technology plan.
Abstract (Originalsprache)
Diabetic nephropathy (DN) is one of the most common complications of diabetes. Gradual loss of podocytes is a sign of DN and pyroptosis mechanistically correlates with podocyte injury in DN; however, the mechanism(s) involved remain unknown. Here we reveal that TRIM29 is overexpressed in high glucose (HG)‐treated murine podocytes cells and that TRIM29 silencing significantly inhibits podocyte damage due to HG treatment, as evidenced by lower desmin expression and greater nephrin expression. Additionally, flow cytometry analysis showed that TRIM29 silencing significantly inhibited HG treatment‐induced pyroptosis, which was confirmed by immunoblotting for NLRP3, active Caspase‐1, GSDMD‐N, and phosphorylated NF‐κB‐p65. Conversely, overexpression of TRIM29 could trigger pyroptosis that was attenuated by NF‐κB inhibition, indicating that TRIM29 promotes pyroptosis through the NF‐κB pathway. Mechanistic studies revealed that TRIM29 interacts with IκBα to mediate its ubiquitination‐dependent degradation, which in turn leads to NF‐κB activation. Taken together, our data demonstrate that TRIM29 can promote podocyte pyroptosis by activating the NF‐κB/NLRP3 pathway. Thus, TRIM29 represents a potentially novel therapeutic target that may also be clinically relevant in the management of DN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, China.
- Department of Nephrology, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, China.
- Department of Endocrinology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
- Department of Neurosurgery, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, China.
- Department of Neurosurgery, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, China.
Förderung
- Excellent talent fund project, development fund of Affiliated Hospital of Xuzhou Medical University
- Suqian guiding science and technology plan
Zitieren
APA
Xu, X., Qin, Z., Zhang, C., Mi, X., Zhang, C., Zhou, F., Wang, J., Zhang, L., & Hua, F. (2023). TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway. Cell Biology International. https://doi.org/10.1002/cbin.12006
Vancouver
Xu X, Qin Z, Zhang C, Mi X, Zhang C, Zhou F, et al. TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway. Cell Biology International. 2023. doi:10.1002/cbin.12006
BibTeX
@article{Xu2023,
author = {Xu, Xiaohong and Qin, Zihan and Zhang, Ce and Mi, Xia and Zhang, Chi and Zhou, Feihong and Wang, Junsheng and Zhang, Liexiang and Hua, Fei},
title = {TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway},
journal = {Cell Biology International},
year = {2023},
doi = {10.1002/cbin.12006}
}
EUVIMED